Forcefieldtx

2 known investors

Forcefield Therapeutics develops cardioprotective proteins for the treatment of cardiac disease, with an initial focus on myocardial infarction (heart attack). It holds an exclusive licence to these proteins and operates a virtual business model working with strategic and operational partners.

BiotechHealthtechMedical Devices